MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.05.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
2015 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
10.1 M |
Marktkapitalisierung |
$ 1.54 M |
EBITDA (LTM) |
$ -10.5 M |
P/E (LTM) |
- |
P/S (LTM) |
0.32 |
EPS (LTM) |
1.68 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Celcuity
CELC
|
$ 88.4 | -4.4 % | $ 4.13 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Co-Diagnostics
CODX
|
$ 5.87 | 1.91 % | $ 7.81 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 21.09 | -2.36 % | $ 611 M | Nasdaq Global Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 18.88 | -3.18 % | $ 581 M | Nasdaq Global Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Guardant Health
GH
|
$ 126.53 | -4.91 % | $ 15.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.67 | -6.7 % | $ 7.39 M | Nasdaq Global Select Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Illumina
ILMN
|
$ 161.59 | -3.85 % | $ 25 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 22.23 | -3.87 % | $ 1.18 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
ICON Public Limited Company
ICLR
|
$ 149.63 | -2.07 % | $ 11.7 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 100.78 | -1.98 % | $ 6.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 10.84 | -4.16 % | $ 1.39 B | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 216.4 | -2.57 % | $ 29.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 181.01 | -2.59 % | $ 8.97 B | NYSE,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.45 | -11.18 % | $ 435 M | Nasdaq Global Select Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 454.25 | -0.97 % | $ 13.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 151.0 | -2.5 % | $ 23.7 B | NYSE,SPB |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.56 | -2.88 % | $ 422 M | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 19.13 | -3.16 % | $ 428 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 10.78 | -10.95 % | $ 962 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.03 | 0.13 % | $ 24.7 B | NYSE |  Niderland |
 |
Senseonics Holdings
SENS
|
$ 6.65 | -5.14 % | $ 277 M | NYSE American | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.08 | -3.19 % | $ 4.78 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 265.69 | 1.75 % | $ 22.1 B | NYSE,SPB | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 69.46 | -6.05 % | $ 4.15 B | Nasdaq Global Select Market,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 470.97 | -2.3 % | $ 178 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.68 | -0.95 % | $ 244 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Waters Corporation
WAT
|
$ 365.69 | -2.85 % | $ 21.8 B | NYSE,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 8.83 | -3.18 % | $ 1.92 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 199.86 | 1.89 % | $ 22.2 B | NYSE,SPB | USA |